Search by Drug Name or NDC
NDC 11673-0191-01 SENNA LAXATIVE 8.6 mg/1 Details
SENNA LAXATIVE 8.6 mg/1
SENNA LAXATIVE is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TARGET CORPORATION. The primary component is SENNOSIDES A AND B.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 11673-0191-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 11673-0191 |
|---|---|
| Product ID | 11673-191_86a77a11-d8c6-0e65-e053-2a91aa0aa8cb |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | SENNA LAXATIVE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SENNOSIDES 8.6 MG |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8.6 |
| Active Ingredient Units | mg/1 |
| Substance Name | SENNOSIDES A AND B |
| Labeler Name | TARGET CORPORATION |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 11673-0191-01 (11673019101)
| NDC Package Code | 11673-191-01 |
|---|---|
| Billing NDC | 11673019101 |
| Package | 100 TABLET in 1 BOTTLE (11673-191-01) |
| Marketing Start Date | 2019-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 7cab058f-3647-7124-e053-2a91aa0a41bd Details
INACTIVE INGREDIENTS
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
|
Directions: Take preferably at bedtime or as directed by a doctor; if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable. Adults and children 12 years and over - starting dosage: 2 tablets once a day Maximum dosage: 4 tablets twice a day Children 6 to under 12 years - starting dosage: 1 tablet once a day Maximum dosage: 2 tablets twice a day Children 2 to under 6 years - starting dosage: 1/2 tablet once a day Maximum dosage: 1 tablet twice a day Children under 2 years - ask a doctor |
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
| SENNA LAXATIVE
sennosides 8.6 mg tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Labeler - TARGET CORPORATION (006961700) |
| Registrant - TIME CAP LABORATORIES, INC. (037052099) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| TIME CAP LABORATORIES INC | 037052099 | manufacture(11673-191) | |